Factors associated with adherence to adjuvant endocrine therapy in patients with hormone receptor positive breast cancer.

被引：0
|
作者：
Kim, Jongjin
Han, Wonshik
Moon, Hyeong-Gon
Kim, Jisun
Lee, Jun Woo
Kim, Min Kyoon
Lee, Eunshin
Yoo, Tae-Kyung
Noh, Dong Young
机构：
[1] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Surg, Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e11502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11502
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
    Lambertini, Matteo
    Viglietti, Giulia
    de Azambuja, Evandro
    ESMO OPEN, 2018, 3 (03)
  • [32] Radiotherapy vs. endocrine therapy for hormone receptor positive early stage breast cancer accounting for endocrine therapy adherence
    Seol, Seung Won
    Pflederer, Travis
    Weller, Lauren
    Goodman, Chelain
    Donnelly, Eric D.
    Hayes, John P.
    Strauss, Jonathan B.
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yan, Yi-Dan
    Fu, Jie
    Gu, Zhi-Chun
    Lu, Jin-Song
    Su, Ying-Jie
    Lin, Hou-Wen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01) : 184 - 190
  • [34] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yi-Dan Yan
    Jie Fu
    Zhi-Chun Gu
    Jin-Song Lu
    Ying-Jie Su
    Hou-Wen Lin
    International Journal of Clinical Pharmacy, 2023, 45 : 184 - 190
  • [35] Risk of recurrence following 5 years of adjuvant hormone therapy for hormone receptor positive early breast cancer.
    Lohrisch, C.
    Speers, C.
    Chia, S.
    Kennecke, H.
    Ellard, S.
    Tyldesley, S.
    CANCER RESEARCH, 2013, 73
  • [36] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
    Pan, Kathy
    Chlebowski, Rowan T.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
  • [37] Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
    Nardin, Simone
    Ruelle, Tommaso
    Giannubilo, Irene
    Del Mastro, Lucia
    TUMORI JOURNAL, 2024, 110 (03): : 162 - 167
  • [38] Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system
    Candyce H. Kroenke
    Dawn L. Hershman
    Scarlett L. Gomez
    Sara R. Adams
    Elizabeth H. Eldridge
    Marilyn L. Kwan
    Isaac J. Ergas
    Ai Kubo
    Lawrence H. Kushi
    Breast Cancer Research and Treatment, 2018, 170 : 623 - 631
  • [39] Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system
    Kroenke, Candyce H.
    Hershman, Dawn L.
    Gomez, Scarlett L.
    Adams, Sara R.
    Eldridge, Elizabeth H.
    Kwan, Marilyn L.
    Ergas, Isaac J.
    Kubo, Ai
    Kushi, Lawrence H.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (03) : 623 - 631
  • [40] Primary non-adherence to adjuvant endocrine therapy in older women with breast cancer.
    Tchuente, Vanina
    Stern, Donna
    Prchal, Jaroslav
    Martin, Judy
    Tamblyn, Robyn
    Meguerditchian, Ari N.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
12345